How should I manage a patient who tested negative on a home COVID-19 swab 3 days ago but was diagnosed COVID‑19 in clinic about 9 days ago, now presenting with worsening symptoms and ear popping, and who has a history of allergic rhinitis and recurrent acute otitis media?

Treat this patient as presumed COVID-19 with secondary complications despite the negative home test

This patient likely has persistent COVID-19 with secondary Eustachian tube dysfunction and possible acute otitis media, and should be managed with symptomatic treatment for both conditions while considering antiviral therapy if still within the treatment window.

Clinical Reasoning

COVID-19 Status Assessment

The negative home swab 3 days ago does not rule out active COVID-19 infection. Research demonstrates that patients with typical COVID-19 symptoms can have repeatedly negative PCR tests yet show serologic confirmation of infection, with seropositivity rates of 60% in symptomatic RT-PCR negative patients 1. More critically, viral RNA can persist in specific anatomic sites even when nasopharyngeal swabs are negative 2, 3.

Key point: The patient is now 9 days post-diagnosis with worsening symptoms—this represents potential clinical deterioration that requires urgent assessment.

Ear Symptoms in COVID-19 Context

The ear popping and worsening symptoms are highly relevant. COVID-19, particularly Omicron variants, causes secretory otitis media through Eustachian tube dysfunction 3. SARS-CoV-2 RNA has been detected in middle ear effusion even when nasopharyngeal swabs are negative 3. The patient's extensive history of allergic rhinitis compounds this risk, as allergic rhinitis significantly increases odds of otitis media (OR 2.19-2.46) 4.

Management Algorithm

Immediate Actions

1. Establish treatment escalation plan - Per NICE guidelines, patients with COVID-19 can deteriorate rapidly and need urgent hospital admission planning 5

2. Assess for severe disease indicators:

   • Oxygen saturation
   • Respiratory rate
   • Work of breathing
   • Ability to complete sentences

3. Otoscopic examination to differentiate:

   • Acute otitis media (bulging, erythematous tympanic membrane)
   • Secretory otitis media (retracted membrane, visible effusion, air-fluid levels)
   • Simple Eustachian tube dysfunction

Treatment Approach

For COVID-19 symptoms:

• Consider antiviral therapy (nirmatrelvir/ritonavir) if patient meets eligibility criteria and is within treatment window (typically 5-7 days from symptom onset, though patient is at day 9) 6
• For distressing cough: short-term codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution 5
• Controlled breathing techniques including positioning and pursed-lip breathing 5

For ear symptoms:

• Intranasal corticosteroids for allergic rhinitis component (addresses underlying Eustachian tube inflammation)
• Oral decongestants if not contraindicated
• If acute otitis media is confirmed: standard antibiotic therapy
• Avoid myringotomy unless complications develop (facial paralysis, mastoiditis) 7

Critical Pitfalls to Avoid

Do not dismiss worsening symptoms based on the negative home test. The combination of clinical presentation, prior positive test, and typical symptom progression supersedes a single negative test result 1, 2, 8. Clinical diagnosis should guide treatment decisions independent of RT-PCR results 1.

Do not attribute all symptoms to allergic rhinitis alone. While the patient has extensive allergic rhinitis history, the temporal relationship to COVID-19 diagnosis and symptom worsening suggests COVID-related complications 9, 3.

Monitoring Plan

Provide clear instructions to contact emergency services or return immediately if:

• Breathing difficulty worsens
• Inability to speak in full sentences
• Confusion or altered mental status
• Persistent chest pain
• Oxygen saturation drops (if home monitoring available)

The patient's history of reactive airway disease increases risk for respiratory deterioration 9, making close monitoring essential.